Neuronetics, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
Neuronetics, Inc. (STIM) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent of -4.60% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense · last filed 2025-03-27
- Neuronetics, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2024 was -4.60%, a 1020.00% decline from fiscal 2023.
- Neuronetics, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2023 was 0.50%.
- Neuronetics, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2022 was -2.30%, a 121.70% decline from fiscal 2021.
- Neuronetics, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2021 was 10.60%, a 1225.00% increase from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month as first filed |
|---|---|---|
| 2024-12-31 | -4.60% 10-K · filed 2025-03-27 | |
| 2023-12-31 | 0.50% 10-K · filed 2025-03-27 | |
| 2022-12-31 | -2.30% 10-K · filed 2025-03-27 | 2.30% 10-K · filed 2023-03-07 |
| 2021-12-31 | 10.60% 10-K · filed 2024-03-08 | -10.60% 10-K · filed 2022-03-08 |
| 2020-12-31 | 0.80% 10-K · filed 2023-03-07 | |
| 2019-12-31 | -6.40% 10-K · filed 2022-03-08 | |
| 2018-12-31 | -0.70% 10-K · filed 2021-03-02 | |
| 2017-12-31 | 0.30% 10-K · filed 2020-03-03 | |
| 2016-12-31 | 1.20% 10-K · filed 2019-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |